Study: HDL cholesterol, heart risk aren't linked in statin users

07/22/2010 | HealthDay News

A U.S. study suggests that patients with a low level of LDL, or "bad," cholesterol as a result of using a high-dose statin, such as AstraZeneca's Crestor, might not benefit from a high level of HDL, or "good," cholesterol. The finding suggests that "once on a high-dose statin, it is unclear if HDL cholesterol remains an important determinant of residual risk" of cardiovascular disease, the lead author said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA